Vasilis Tsimihodimos

Associate Professor

University of Ioannina School of Medicine

Greece

Research Interests

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Vasilis Tsimihodimos is an Associate Professor at the University of Ioannina, School of Medicine, Greece. His research areas include cardiovascular disease risk factors, metabolic diseases, and diabetes management. Recent articles have focused on HDL lipid profiles, the effects of dietary components like extra virgin olive oil, and the implications of various treatments on patient health outcomes, particularly in populations with chronic conditions.

Articles (15)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (6)

Matilda Florentin

University of Ioannina

GREECE

View details

Ele Ferrannini

University of Pisa

ITALY

View details

Areti Kourti

Aristotle University of Thessaloniki

GREECE

View details

Kali Makedou

Associate Professor

Aristotle University of Thessaloniki

GREECE

View details

Omar G. Mustafa

Honorary senior lecturer

King’s College London

UNITED KINGDOM

View details

Christina E. Kostara

University of Ioannina

GREECE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Vasilis Tsimihodimos

Research Interests

Contact this professor

About

Articles (15)

Altered HDL Phospholipid and Fatty Acid Profile in MASLD: A Possible Explanation for the Increased CVD Risk

Evaluating Guideline Alignment by Analyzing Patient Profiles of Elderly People with Type 2 Diabetes and Chronic Kidney Disease Treated or Not with SGLT2 Inhibitors

Obesity, but Not Overweight, Is Associated with Increased Presepsin Levels in Infection-Free Individuals: An Exploratory Study

Extra Virgin Olive Oil and Metabolic Diseases

GLP-1 Receptor Agonists and Diabetic Kidney Disease: A Game Charger in the Field?

Effect of fixed-dose combination of insulin degludec and liraglutide on apoB-containing lipoprotein subclasses and HDL lipidome in type 2 diabetes

Fasting Substrate Concentrations Predict Cardiovascular Outcomes in the CANagliflozin cardioVascular Assessment Study (CANVAS)

Progressive, Qualitative, and Quantitative Alterations in HDL Lipidome from Healthy Subjects to Patients with Prediabetes and Type 2 Diabetes

Serum Uric Acid Levels and Cardiometabolic Profile in Middle-Aged, Treatment-Naïve Hypertensive Patients

The Critical Role of the Branched Chain Amino Acids (BCAAs) Catabolism-Regulating Enzymes, Branched-Chain Aminotransferase (BCAT) and Branched-Chain α-Keto Acid Dehydrogenase (BCKD), in Human Pathophysiology

Adherence to Treatment, Arterial Stiffness and Cognitive Function in Irbesartan- Treated Newly Diagnosed Hypertensive Patients.

Altered RBC membrane lipidome: A possible etiopathogenic link for the microvascular impairment in Type 2 diabetes

Cost-effectiveness of Empagliflozin Compared with Dapagliflozin for the Treatment of Patients with Type 2 Diabetes Mellitus and Established Cardiovascular Disease in Greece

Effect of Dapagliflozin on Urine Metabolome in Patients with Type 2 Diabetes

Insights Into the Results of Sotagliflozin Cardiovascular Outcome Trials: Is Dual Inhibition the Cherry on the Cake of Cardiorenal Protection?

Collaborators (6)

Matilda Florentin

Ele Ferrannini

Areti Kourti

Kali Makedou

Omar G. Mustafa

Christina E. Kostara

Make your next move.